Treatment of epilepsy in China: Formal or informal?

Neural Regeneration Research

Volumn 8, Issue 35, 2013, Pages 3316-3324

  Liu, Jian Ming ^a   Liu, Zhi Liang ^a   Chen, Tao ^b   Xu, Ru Xiang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Cross sectional survey; Drug treatment; Epilepsy; Grants supported paper; Intractable epilepsy; Nervous system diseases; Neural regeneration; Neuroregeneration; Normalization; Retrospective study; Survey; Treatment regimen

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ACUPUNCTURE; ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CATGUT EMBEDDING; CHILD; CHINA; CHINESE MEDICINE; CROSS-SECTIONAL STUDY; EPILEPSY; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHYSICIAN; QUESTIONNAIRE; RETROSPECTIVE STUDY; SEIZURE; SUPERSTITION; TONIC CLONIC SEIZURE; CLINICAL ASSESSMENT; DISEASE ASSESSMENT; DISEASE COURSE; HEALTH CARE COST; HEALTH SURVEY; INTRACTABLE EPILEPSY; PHYSICIAN ATTITUDE; TRADITIONAL MEDICINE;

EID: 84892714396     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.35.006     Document Type: Article

References (54)

1. Neligan A, Hauser WA, Sander JW. The epidemiology of the epilepsies. Handb Clin Neurol. 2012;107:113-133.
2. Campos MG. Epilepsy surgery in developing countries. Handb Clin Neurol. 2012;108:943-953.
3. Pi X, Cui L, Liu A, et al. Investigation of prevalence, clinical characteristics and management of epilepsy in Yueyang city of China by a door-to-door survey. Epilepsy Res. 2012;101(1-2):129-134.
4. Bazil CW, Pedley TA. Clinical pharmacology of antiepileptic drugs. Clin Neuropharmacol. 2003;26(1):38-52.
5. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314-319.
6. Sander JW. Some aspects of prognosis in the epilepsies: a review. Epilepsia. 1993;34(6):1007-1016.
7. Hui AC, Wong A, Wong HC, et al. Refractory epilepsy in a Chinese population. Clin Neurol Neurosurg. 2007;109(8): 672-675.
8. Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat. 2007; 3(1):117-131.
9. Nevalainen O, Auvinen A, Ansakorpi H, et al. Mortality by clinical characteristics in a tertiary care cohort of adult patients with chronic epilepsy. Epilepsia. 2012;53(12):e212-214.
10. Loring DW, Meador KJ. Epilepsy: maximizing cognitive outcomes in epilepsy. Nat Rev Neurol. 2012;8(8):416-417.
11. Buchhalter JR. The relationship between nocturnal discharges and language dysfunction in rolandic epilepsy: treat the child, not the adage. Epilepsy Curr. 2012;12(5): 192-193.
12. Quintas R, Raggi A, Giovannetti AM, et al. Psychosocial difficulties in people with epilepsy: A systematic review of literature from 2005 until 2010. Epilepsy Behav. 2012; 25(1):60-67.
13. Mitchell WG. Social outcome of childhood epilepsy: associations and mechanisms. Semin Pediatr Neurol. 1994; 1(2):136-143.
14. Sillanpaa M, Jalava M, Kaleva O, et al. Long-term prognosis of seizures with onset in childhood. N Engl J Med. 1998;338(24):1715-1722.
15. Thorbecke R, Pfafflin M. Social aspects of epilepsy and rehabilitation. Handb Clin Neurol. 2012;108:983-999.
16. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from populationbased clinical and survey data. Epilepsia. 2000;41(3):342-351.
17. Manjunath R, Davis KL, Candrilli SD, et al. Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav. 2009;14(2): 372-378.
18. Hovinga CA, Asato MR, Manjunath R, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav. 2008;13(2):316-322.
19. Hijikata Y, Yasuhara A, Yoshida Y, et al. Traditional Chinese medicine treatment of epilepsy. J Altern Complement Med. 2006;12(7):673-677.
20. Cunnington MC, Webb DJ, Irizarry MC, et al. Risk factors for antiepileptic drug regimen change in patients with newly diagnosed epilepsy. Epilepsy Behav. 2011;21(2): 168-172.
21. Blume WT, Luders HO, Mizrahi E, et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia. 2001;42(9):1212-1218.
22. Sillanpaa M. Remission of seizures and predictors of intractability in long-term follow-up. Epilepsia. 1993;34(5): 930-936.
23. Smith D, Defalla BA, Chadwick DW. The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. QJM. 1999;92(1):15-23.
24. Schachter SC. Antiepileptic drug therapy: general treatment principles and application for special patient populations. Epilepsia. 1999;40 Suppl 9:S20-25.
25. Annegers JF, Hauser WA, Shirts SB, et al. Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med. 1987;316(9):493-498.
26. Leone MA, Solari A, Beghi E. Treatment of the first tonicclonic seizure does not affect long-term remission of epilepsy. Neurology. 2006;67(12):2227-2229.
27. Musicco M, Beghi E, Solari A, et al. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology. 1997;49(4):991-998.
28. Camfield C, Camfield P, Gordon K, et al. Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less. Neurology. 1996;46(1):41-44.
29. Saito M, Munana KR, Sharp NJ, et al. Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effects of status epilepticus on outcome and survival time: 32 cases (1990-1996). J Am Vet Med Assoc. 2001;219(5):618-623.
30. Brodie MJ, French JA. Management of epilepsy in adolescents and adults. Lancet. 2000;356(9226):323-329.
31. Heaney DC, Beran RG, Halpern MT. Economics in epilepsy treatment choices: our certain fate? Epilepsia. 2002;43Suppl 4:32-38.
32. Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy? Epilepsia. 1981;22(1):1-10.
33. Callaghan N, Kenny RA, O'Neill B, et al. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry. 1985;48(7):639-644.
34. Ishikawa A, Sakuma N, Nagashima T, et al. Clonazepam monotherapy for epilepsy in childhood. Brain Dev. 1985; 7(6):610-613.
35. Brodie MJ, Yuen AW. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res. 1997;26(3):423-432.
36. Shorvon SD, Chadwick D, Galbraith AW, et al. One drug for epilepsy. Br Med J. 1978;1(6111):474-476.
37. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47(7):1094-1120.
38. Bill PA, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res. 1997;27(3):195-204.
39. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet. 1995;345(8948):476-479.
40. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med. 1992;327(11):765-771.
41. Dam M, Ekberg R, Loyning Y, et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res. 1989;3(1):70-76.
42. Brodie MJ, Kwan P. The star systems: overview and use in determining antiepileptic drug choice. CNS Drugs. 2001;15(1):1-12.
43. Guerreiro MM, Vigonius U, Pohlmann H, et al. A doubleblind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997;27(3):205-213.
44. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2009;51(6):1069-1077.
45. Kwan P, Brodie MJ. Combination therapy in epilepsy: when and what to use. Drugs. 2006;66(14):1817-1829.
46. Carpay JA, Aldenkamp AP, van Donselaar CA. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure. 2005;14(3): 198-206.
47. Canevini MP, De Sarro G, Galimberti CA, et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 2010;51(5):797-804.
48. Stephen LJ, Brodie MJ. Seizure freedom with more than one antiepileptic drug. Seizure. 2002;11(6):349-351.
49. Schiller Y, Najjar Y. Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology. 2008;70(1):54-65.
50. Yeager KA, Diiorio C, Shafer PO, et al. The complexity of treatments for persons with epilepsy. Epilepsy Behav. 2005;7(4):679-686.
51. Baker GA, Jacoby A, Buck D, et al. Quality of life of people with epilepsy: a European study. Epilepsia. 1997;38(3): 353-362.
52. Li Q, Chen X, He L, et al. Traditional Chinese medicine for epilepsy. Cochrane Database Syst Rev. 2009(3): CD006454.
53. Cheuk DK, Wong V. Acupuncture for epilepsy. Cochrane Database Syst Rev. 2008(4):CD005062.
54. de Tisi J, Bell GS, Peacock JL, et al. The long-term out-come of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet. 2011; 378(9800):1388-1395.